MassDevice looks for a silver lining for medical device companies in the U.S. Supreme Court's decision to uphold the Patient Protection & Affordable Care Act,
Uncertainty is bad for business, so in some respects the U.S. Supreme Court's decision to uphold the the healthcare reform law yesterday morning carries a bit of a silver lining, despite the obvious negative that the excise tax on medical device makers will live on.
If you don't believe me, ask Katherine Owen, Stryker Corp's VP of strategy and investor relations, who said as much in an investor's conference last week.
"My biggest fear is that the Supreme Court just pushes off on the whole thing and says, 'This is a tax, and under law as it is currently constructed, the Supreme Court is not allowed to weigh in on the legality of the tax for a year, so we will revisit this in 2014,'" she said. "That would create just another overhang. For me, that is the worst-case scenario."